These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 30926888
1. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis. Zhao G, Wang C, Tang Y, Liu X, Liu Z, Li G, Mei Y. Sci Rep; 2019 Mar 29; 9(1):5323. PubMed ID: 30926888 [Abstract] [Full Text] [Related]
2. [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation]. Wang C, Sun ZQ, Liu MY, Zhang JJ, Liu G, Feng Y, Yan YF, Cui HW, Li G. Zhonghua Zhong Liu Za Zhi; 2021 Jun 23; 43(6):691-695. PubMed ID: 34289563 [Abstract] [Full Text] [Related]
3. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. Li G, Yu J, Song H, Zhu S, Sun L, Shang Z, Niu Y. BMC Cancer; 2017 Aug 08; 17(1):530. PubMed ID: 28789622 [Abstract] [Full Text] [Related]
4. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y. J Urol; 2009 Jul 08; 182(1):78-84; discussion 84. PubMed ID: 19447418 [Abstract] [Full Text] [Related]
5. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A. Eur Urol; 2014 Jan 08; 65(1):218-26. PubMed ID: 22633802 [Abstract] [Full Text] [Related]
6. Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer. Li G, Song H, Wang J, Bao Y, Niu Y. Sci Rep; 2016 Jun 09; 6():27586. PubMed ID: 27279531 [Abstract] [Full Text] [Related]
7. Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece. Ukai R, Hashimoto K, Nakayama H, Iwamoto T. Jpn J Clin Oncol; 2017 May 01; 47(5):447-452. PubMed ID: 28184446 [Abstract] [Full Text] [Related]
8. Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection. Luo Q, Liu Y, Zhao H, Guo P, Wang Q, Li W, Li G, Wu B. World J Urol; 2020 Nov 01; 38(11):2849-2856. PubMed ID: 31965287 [Abstract] [Full Text] [Related]
11. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA. J Urol; 2012 Aug 01; 188(2):405-9. PubMed ID: 22704101 [Abstract] [Full Text] [Related]
12. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. Urol Oncol; 2013 Oct 01; 31(7):1141-7. PubMed ID: 22056404 [Abstract] [Full Text] [Related]
14. Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results. Ma B, Li Y, Han S, Jiang X, Zhao Y, Guo J, Quan C, Niu Y. Eur J Surg Oncol; 2019 Oct 01; 45(10):1993-1999. PubMed ID: 31327502 [Abstract] [Full Text] [Related]
15. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. World J Urol; 2018 Feb 01; 36(2):249-256. PubMed ID: 29185045 [Abstract] [Full Text] [Related]
16. Outcomes of squamous histology in bladder cancer: a population-based study. Izard JP, Siemens DR, Mackillop WJ, Wei X, Leveridge MJ, Berman DM, Peng Y, Booth CM. Urol Oncol; 2015 Oct 01; 33(10):425.e7-13. PubMed ID: 26199176 [Abstract] [Full Text] [Related]
17. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. BJU Int; 2016 Feb 01; 117(2):272-9. PubMed ID: 25381844 [Abstract] [Full Text] [Related]
18. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y. Eur J Surg Oncol; 2013 Oct 01; 39(10):1150-6. PubMed ID: 23721764 [Abstract] [Full Text] [Related]
20. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder. Minato A, Noguchi H, Tomisaki I, Fukuda A, Kubo T, Nakayama T, Fujimoto N. Cancer Control; 2018 Oct 01; 25(1):1073274818800269. PubMed ID: 30213195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]